AstraZeneca Signs Deal in Patient-Driven R&D
In move o make patient-centric evidence a part of its scientific discovery and development, AstraZeneca has partnered withPatientsLikeMe, a patient network with a real-time research platform, in a five-year agreement that provides access to PatientsLikeMe's global network in support of AstraZeneca's research initiatives.
AstraZeneca will use patient-reported data from PatientsLikeMe to shape future medicine development and help improve outcomes across its main therapeutic areas, with an initial focus on respiratory disease, lupus, diabetes, and oncology.
PatientsLikeMe is a patient network that improves lives and a real-time research platform that advances medicine. Through the network, patients connect with others who have the same disease or condition and track and share their own experiences. In the process, they generate data about the real-world nature of disease that help researchers, pharmaceutical companies, regulators, providers, and nonprofits develop more effective products, services and care. The network has more than 325,000 members.